Jesús María
Hernández Rivas
Catedrático de Universidad
Hospital Universitario de Basurto
Bilbao, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Basurto (2)
2024
-
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial
Haematologica, Vol. 109, Núm. 2, pp. 543-552
2015
-
Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations
British Journal of Haematology